Engineering G protein-coupled receptors to facilitate their structure determination

Current Opinion in Structural Biology

Volumn 19, Issue 4, 2009, Pages 386-395

  Tate, Christopher G ^a   Schertler, Gebhard FX ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11 CIS RETINAL; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE A2A RECEPTOR; ARGININE; BACTERIORHODOPSIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARAZOLOL; CYANOPINDOLOL; DETERGENT; G PROTEIN COUPLED RECEPTOR; OPSIN; RHODOPSIN; TIMOLOL;

CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; COW; CRYSTAL STRUCTURE; CRYSTALLIZATION; GENETIC CONSERVATION; HUMAN; INSECT CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SQUID; STRUCTURE ANALYSIS;

ANIMALS; HUMANS; PROTEIN ENGINEERING; RECEPTORS, G-PROTEIN-COUPLED;

BOVINAE; CEPHALOPODA; HEXAPODA; MAMMALIA;

EID: 69249146075     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2009.07.004     Document Type: Review

References (65)

1. Fredriksson R., and Schioth H.B. The repertoire of G protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67 (2005) 1414-1425
2. Baldwin J.M., Schertler G.F., and Unger V.M. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G protein-coupled receptors. J Mol Biol 272 (1997) 144-164
3. Madabushi S., Gross A.K., Philippi A., Meng E.C., Wensel T.G., and Lichtarge O. Evolutionary trace of G protein-coupled receptors reveals clusters of residues that determine global and class-specific functions. J Biol Chem 279 (2004) 8126-8132
4. Kobilka B.K., and Deupi X. Conformational complexity of G protein-coupled receptors. Trends Pharmacol Sci 28 (2007) 397-406
5. Galandrin S., and Bouvier M. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol Pharmacol 70 (2006) 1575-1584
6. Baker J.G., Hall I.P., Hill S.J., and Agonist. inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling. Mol Pharmacol 64 (2003) 1357-1369
7. Kenakin T. Ligand-selective receptor conformations revisited, the promise and the problem. Trends Pharmacol Sci 24 (2003) 346-354
8. Kenakin T. Collateral efficacy in drug discovery, taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28 (2007) 407-415
9. Hopkins A.L., and Groom C.R. The druggable genome. Nat Rev Drug Discov 1 (2002) 727-730
10. Schertler G.F., Villa C., and Henderson R. Projection structure of rhodopsin. Nature 362 (1993) 770-772
11. Unger V.M., and Schertler G.F. Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. Biophys J 68 (1995) 1776-1786
12. Unger V.M., Hargrave P.A., Baldwin J.M., and Schertler G.F. Arrangement of rhodopsin transmembrane alpha-helices. Nature 389 (1997) 203-206
13. Schertler G.F. Structure of rhodopsin and the metarhodopsin I photointermediate. Curr Opin Struct Biol 15 (2005) 408-415
14. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
15. Li J., Edwards P.C., Burghammer M., Villa C., and Schertler G.F.X. Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol 343 (2004) 1409-1438
16. Okada T., Sugihara M., Bondar A.N., Elstner M., Entel P., and Buss V. The retinal conformation and its environment in rhodopsin in light of a new 2.2 Å crystal structure. J Mol Biol 342 (2004) 571-583
17. Deupi X., Dolker N., Lopez-Rodriguez M.L., Campillo M., Ballesteros J.A., and Pardo L. Structural models of class a G protein-coupled receptors as a tool for drug design, insights on transmembrane bundle plasticity. Curr Top Med Chem 7 (2007) 991-998
18. Standfuss J., Xie G., Edwards P.C., Burghammer M., Oprian D.D., and Schertler G.F. Crystal structure of a thermally stable rhodopsin mutant. J Mol Biol 372 (2007) 1179-1188. First structure of a recombinant GPCR. Linking the N-terminal micro-domain to external loop 3 by an engineered disulphide bridge increased the themostability of rhodopsin in detergent. The structure was obtained with a 5-μm X-ray beam from a single micro-crystal.
19. ab antibody fragment to increase the hydrophilic surface, in addition to the stabilisation of the receptor by the bicelles, suggests a strategy that could be applied to many other GPCRs.
20. 2 adrenergic receptor. A T4 lysozyme fusion in the third intracellular loop was essential for the crystallisation of the receptor in lipidic cubic phase.
21. Hanson M.A., Cherezov V., Griffith M.T., Roth C.B., Jaakola V.P., Chien E.Y., Velasquez J., Kuhn P., and Stevens R.C. A specific cholesterol binding site is established by the 2.8 Å structure of the human beta2-adrenergic receptor. Structure 16 (2008) 897-905
22. 1 receptor is unstable, conformational thermostabilisation was essential to allow crystallisation in short-chain detergents without the requirement of gene fusions or antibody fragments.
23. 2AR, T4L.
24. Murakami M., and Kouyama T. Crystal structure of squid rhodopsin. Nature 453 (2008) 363-367
25. Shimamura T., Hiraki K., Takahashi N., Hori T., Ago H., Masuda K., Takio K., Ishiguro M., and Miyano M. Crystal structure of squid rhodopsin with intracellularly extended cytoplasmic region. J Biol Chem 283 (2008) 17753-17756
26. ••].
27. •] provides the closest current view of an active-like state of a GPCR. Both structures show the large movement of the intracellular end of helix 6. The C-terminal G protein peptide directly interacts with the most conserved (E/D)RY sequence.
28. Grisshammer R., and Tate C.G. Overexpression of integral membrane proteins for structural studies. Q Rev Biophys 28 (1995) 315-422
29. McKibbin C., Farmer N.A., Jeans C., Reeves P.J., Khorana H.G., Wallace B.A., Edwards P.C., Villa C., and Booth P.J. Opsin stability and folding, modulation by phospholipid bicelles. J Mol Biol 374 (2007) 1319-1332
30. Faham S., and Bowie J.U. Bicelle crystallization, a new method for crystallizing membrane proteins yields a monomeric bacteriorhodopsin structure. J Mol Biol 316 (2002) 1-6
31. Kobilka B.K. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal Biochem 231 (1995) 269-271
32. Gether U., Ballesteros J.A., Seifert R., Sanders-Bush E., Weinstein H., and Kobilka B.K. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272 (1997) 2587-2590
33. Day P.W., Rasmussen S.G., Parnot C., Fung J.J., Masood A., Kobilka T.S., Yao X.J., Choi H.J., Weis W.I., Rohrer D.K., and Kobilka B.K. A monoclonal antibody for G protein-coupled receptor crystallography. Nat. Methods 4 (2007) 927-929
34. Riekel C., Burghammer M., and Schertler G. Protein crystallography microdiffraction. Curr Opin Struct Biol 15 (2005) 556-562
35. ••].
36. Engel C.K., Chen L., and Prive G.G. Insertion of carrier proteins into hydrophilic loops of the Escherichia coli lactose permease. Biochim Biophys Acta 1564 (2002) 38-46
37. Alexandrov A.I., Mileni M., Chien E.Y., Hanson M.A., and Stevens R.C. Microscale fluorescent thermal stability assay for membrane proteins. Structure 16 (2008) 351-359. An excellent, rapid assay for determining the thermostability of purified membrane proteins using a maleimide that fluoresces upon reaction with internal cysteine residues exposed upon thermal denaturation. This is ideal for optimising protein stability in the presence of different detergents, lipids, buffers, salts and additives.
38. Warne T., Serrano-Vega M.J., Tate C.G., and Schertler G.F. Development and crystallization of a minimal thermostabilized G protein-coupled receptor. Protein Exp Purif 65 (2009) 204-213
39. 1 adrenergic receptor that was essential to allow its crystallisation in short-chain detergents. After thermostabilisation, the receptor was preferentially in the ground state conformation, although it could still couple to G proteins if sufficient agonist was added.
40. Sarkar C.A., Dodevski I., Kenig M., Dudli S., Mohr A., Hermans E., and Pluckthun A. Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity. Proc Natl Acad Sci U S A 105 (2008) 14808-14813. An interesting approach to thermostabilise GPCRs that relies on the weak correlation between improved expression and improved thermostability.
41. 2a receptor to stabilise it in either an agonist-binding or antagonist-binding conformation. The mutations required for stabilising the two different conformations were largely different.
42. Hanson M.A., and Stevens R.C. Discovery of new GPCR biology: one receptor structure at a time. Structure 17 (2009) 8-14
43. Kobilka B., and Schertler G.F. New G protein-coupled receptor crystal structures, insights and limitations. Trends Pharmacol Sci 29 (2008) 79-83
44. Mustafi D., and Palczewski K. Topology of class A G protein-coupled receptors, insights gained from crystal structures of rhodopsins, adrenergic and adenosine receptors. Mol Pharmacol 75 (2009) 1-12
45. Rosenbaum D.M., Rasmussen S.G., and Kobilka B.K. Structural and mechanistic insights into G protein coupled receptor function. Nature 459 (2009) 356-363
46. Dror R.O., Arlow D.H., Borhani D.W., Jensen M.O., Piana S., and Shaw D.E. Identification of two distinct inactive conformations of the {beta}2-adrenergic receptor reconciles structural and biochemical observations. Proc Natl Acad Sci U S A 106 (2009) 4689-4694
47. Wong S.K.F., and Ross E.M. Chimeric muscarinic cholinergic-beta-adrenergic receptors that are functionally promiscuous among G proteins. J Biol Chem 269 (1994) 18968-18976
48. Kim J.M., Altenbach C., Kono M., Oprian D.D., Hubbell W.L., and Khorana H.G. Structural origins of constitutive activation in rhodopsin: role of the K296/E113 salt bridge. Proc Natl Acad Sci U S A 101 (2004) 12508-12513
49. Rao V.R., and Oprian D.D. Activating mutations of rhodopsin and other G protein-coupled receptors. Annu Rev Biophys Biomol Struct 25 (1996) 287-314
50. Fritze O., Filipek S., Kuksa V., Palczewski K., Hofmann K.P., and Ernst O.P. Role of the conserved NPxxY(x)5.6F motif in the rhodopsin ground state and during activation. Proc Natl Acad Sci U S A 100 (2003) 2290-2295
51. Standfuss J., Zaitseva E., Mahalingam M., and Vogel R. Structural impact of the E113Q counterion mutation on the activation and deactivation pathways of the G protein-coupled receptor rhodopsin. J Mol Biol 380 (2008) 145-157
52. Vogel R., Mahalingam M., Ludeke S., Huber T., Siebert F., and Sakmar T.P. Functional role of the "ionic lock"-an interhelical hydrogen-bond network in family A heptahelical receptors. J Mol Biol 380 (2008) 648-655
53. Mahalingam M., Martinez-Mayorga K., Brown M.F., and Vogel R. Two protonation switches control rhodopsin activation in membranes. Proc Natl Acad Sci U S A 105 (2008) 17795-17800
54. Liu W., Eilers M., Patel A.B., and Smith S.O. Helix packing moments reveal diversity and conservation in membrane protein structure. J Mol Biol 337 (2004) 713-729
55. Smit M.J., Vischer H.F., Bakker R.A., Jongejan A., Timmerman H., Pardo L., and Leurs R. Pharmacogenomic and structural analysis of constitutive G protein-coupled receptor activity. Annu Rev Pharmacol Toxicol 47 (2007) 53-87
56. Sakmar T.P., Menon S.T., Marin E.P., and Awad E.S. Rhodopsin, insights from recent structural studies. Annu Rev Biophys Biomol Struct 31 (2002) 443-484
57. Altenbach C., Kusnetzow A.K., Ernst O.P., Hofmann K.P., and Hubbell W.L. High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation. Proc Natl Acad Sci U S A 105 (2008) 7439-7444
58. Nygaard R., Frimurer T.M., Holst B., Rosenkilde M.M., and Schwartz T.W. Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol Sci 30 (2009) 249-259
59. Deupi X., Dölker N., López-Rodríguez M.L., Campillo M., Ballesteros J.A., and Pardo L. Structural models of Class A G protein-coupled receptors as a tool for drug design: insights on transmembrane bundle plasticity. Current Topics Med Chem 7 (2007) 999-1006
60. Shi L., Liapakis G., Xu R., Guarnieri F., Ballesteros J.A., and Javitch J.A. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J Biol Chem 277 (2002) 40989-40996
61. Ballesteros J.A., Jensen A.D., Liapakis G., Rasmussen S.G., Shi L., Gether U., and Javitch J.A. Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem 276 (2001) 29171-29177
62. Lewis J.W., and Kliger D.S. Absorption spectroscopy in studies of visual pigments, spectral and kinetic characterization of intermediates. Methods Enzymol 315 (2000) 164-178
63. Vogel R., and Siebert F. Fourier transform IR spectroscopy study for new insights into molecular properties and activation mechanisms of visual pigment rhodopsin. Biopolymers 72 (2003) 133-148
64. Valant C., Gregory K.J., Hall N.E., Scammells P.J., Lew M.J., Sexton P.M., and Christopoulos A. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand. J Biol Chem 283 (2008) 29312-29321
65. Pardo L., Deupi X., Dolker N., Lopez-Rodriguez M.L., and Campillo M. The role of internal water molecules in the structure and function of the rhodopsin family of G protein-coupled receptors. Chembiochem 8 (2007) 19-24